Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the benzimidazole class. Its full chemical name is 1-(3-hydroxypropyl)-2-[ (3-nitrobenzoyl)amino ] -1H-benzimidazol -5 - yl pivalate. It has a molecular formula of C22H24N4O6 and a molecular weight of approximately 440.45 g/mol[6][4][7]. The structure features a benzimidazole core substituted with hydroxypropyl and nitrobenzoylamino groups and esterified with pivalic acid. There is no evidence that this compound has been approved for clinical use or that it has an established mechanism of action in humans; it appears to be an experimental or research chemical[6][7]. No information on its pharmacological activity, primary indication, or developer is available in public drug databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 1-(3-hydroxypropyl)-2-[(3-nitrobenzoyl)amino]-1H-benzimidazol-5-yl pivalate.